Webster, Keith A <br/><br/>
Programmed death as a therapeutic target to reduce myocardial infarction.  [electronic resource] 

 -  Trends in pharmacological sciences  Sep 2007 
 - 492-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>0165-6147 
<br/><br/><label>Standard No.: </label>10.1016/j.tips.2007.07.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Ischemic Preconditioning, Myocardial<br/>Myocardial Infarction--therapy<br/>Phosphodiesterase 5 Inhibitors<br/>Proto-Oncogene Proteins c-bcl-2--metabolism